Capula Management Ltd Makes New Investment in Teladoc Health, Inc. (NYSE:TDOC)

Capula Management Ltd bought a new position in Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 33,576 shares of the health services provider’s stock, valued at approximately $305,000.

Other large investors have also made changes to their positions in the company. Arizona State Retirement System increased its holdings in shares of Teladoc Health by 1.8% during the 4th quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock worth $452,000 after purchasing an additional 859 shares during the period. PNC Financial Services Group Inc. increased its stake in Teladoc Health by 22.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider’s stock valued at $73,000 after acquiring an additional 1,439 shares during the period. Lindbrook Capital LLC raised its holdings in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 1,612 shares in the last quarter. Edgestream Partners L.P. lifted its position in shares of Teladoc Health by 0.8% in the 4th quarter. Edgestream Partners L.P. now owns 201,060 shares of the health services provider’s stock worth $1,828,000 after acquiring an additional 1,612 shares during the period. Finally, Jones Financial Companies Lllp grew its holdings in shares of Teladoc Health by 21.4% during the 4th quarter. Jones Financial Companies Lllp now owns 11,792 shares of the health services provider’s stock worth $107,000 after purchasing an additional 2,079 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Insider Activity

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company’s stock, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.95% of the company’s stock.

Teladoc Health Price Performance

NYSE:TDOC opened at $7.23 on Tuesday. The firm’s fifty day moving average price is $10.08 and its two-hundred day moving average price is $9.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a market cap of $1.25 billion, a P/E ratio of -1.25 and a beta of 1.73. Teladoc Health, Inc. has a one year low of $6.61 and a one year high of $15.21.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Analysts Set New Price Targets

TDOC has been the topic of several analyst reports. Royal Bank of Canada boosted their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Oppenheimer dropped their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Bank of America lifted their price objective on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a report on Wednesday, February 12th. The Goldman Sachs Group dropped their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a report on Monday, March 3rd. Finally, Piper Sandler decreased their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $11.26.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.